In two recent decisions, the Madras High Court reversed patent application rejections under Section 3(i), clarifying that only diagnostic methods disclosing pathology per se fall within the exclusion. The Court remanded matters for fresh review, ensuring fair consideration and reasoned decisions by the IPO.
Read more about Section 3(i) Rejections Reversed: Diagnostic Methods Must Disclose Pathology Per Se